Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole Augmentation to Target Anhedonia in Depression
NCT04121091Phase 2Completed
- Sponsor
- Region Skåne
- Start
- Oct 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pramipexole in major depressive disorder (MDD), anhedonia ((none)), sponsored by Region Skåne. Started Oct 2019; status: completed.
02
Drugs
pramipexole
03
Conditions
major depressive disorder (MDD)anhedonia ((none))
Beyond the preview
Go deeper on NCT04121091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04121091.